摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-Tolyl-phosphinsaeure | 20676-63-5

中文名称
——
中文别名
——
英文名称
p-Tolyl-phosphinsaeure
英文别名
p-Tolylphosphonous acid;(4-methylphenyl)phosphonous acid
p-Tolyl-phosphinsaeure化学式
CAS
20676-63-5
化学式
C7H9O2P
mdl
——
分子量
156.121
InChiKey
LBDZCXKTYIWLNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    p-Tolyl-phosphinsaeurep-Tolyl-phosphinsaeure4-甲氧基苯甲醛 生成 [Chloro-(4-methoxy-phenyl)-methyl]-p-tolyl-phosphinic acid
    参考文献:
    名称:
    KARDANOV, N. A.;TIMOFEEV, A. M.;GODOVIKOV, N. N.;PETROVSKIJ, P. V.;KABACH+, DOKL. AN CCCP, 1986, 286, N 6, 1403-1407
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS
    申请人:ATOBE Masakazu
    公开号:US20100029690A1
    公开(公告)日:2010-02-04
    Nitrogen-containing heterocyclic compounds represented by the following Formula (1) are provided. The compounds or salts thereof have a strong EP1 antagonistic activity when they are administered to a human or an animal, and they are useful as an effective component of a pharmaceutical agent for prophylaxis and/or treatment of an overactive bladder, for example. Furthermore, they are useful as an effective component of a pharmaceutical agent for the prophylaxis and/or treatment of symptoms including frequent urination, urinary urgency and urinary incontinence.
    提供以下式(1)所代表的含氮杂环化合物。当这些化合物或其盐被给予人类或动物时,它们具有强烈的EP1拮抗活性,并且它们作为预防或治疗过度活动膀胱的药物的有效成分是有用的,例如。此外,它们作为预防或治疗包括频繁排尿、尿急和尿失禁等症状的药物的有效成分是有用的。
  • Method of producing dinitrile compounds
    申请人:Rosier Cecile
    公开号:US20060258873A1
    公开(公告)日:2006-11-16
    The present invention relates to a process for the manufacture of compounds comprising two nitrile functional groups. It relates more particularly to a process for the manufacture of dinitrile compounds from compounds comprising a nitrile functional group and an ethylenic unsaturation in the presence of a catalytic system comprising an organometallic complex and a cocatalyst of the Lewis acid type. The process of the invention comprises a stage of treatment of the reaction medium resulting from the hydrocyanation which makes it possible to extract and recover the metal element of the Lewis acid.
    本发明涉及一种制备含有两个腈官能团的化合物的方法。更具体地,涉及一种在存在包括一个有机属配合物和一种Lewis酸类辅助催化剂的催化系统的情况下,从含有腈官能团和乙烯不饱和度的化合物制备二腈化合物的方法。本发明的方法包括处理由氢化反应产生的反应介质的阶段,该阶段使得能够提取和回收Lewis酸的属元素。
  • Miscible high Tg polyester/polymer blend compositions and films formed therefrom
    申请人:Hale Raymond Wesley
    公开号:US20060270806A1
    公开(公告)日:2006-11-30
    Disclosed is a high Tg polyester/polymer blend composition for a sheet or film. The composition comprises about 80 to about 99.8 percent by weight of a miscible blend of a polyester with a polymer. Also disclosed is a process for the preparation of a film or sheet from this composition. Compensationa and protective films and sheets prepared from this composition are useful for backlight displays.
    本发明公开了一种用于制作薄膜或薄片的高Tg聚酯/聚合物混合物组合物。该组合物由聚酯和聚合物的可混合混合物约占重量的80%至约99.8%组成。本发明还公开了从该组合物制备薄膜或薄片的过程。使用该组合物制备的补偿和保护膜和薄片适用于背光显示。
  • Polyphenylene ether resin composition of improved heat stability and shaped articles thereof
    申请人:MITSUBISHI GAS CHEMICAL COMPANY, INC.
    公开号:EP0036278A1
    公开(公告)日:1981-09-23
    A polyphenylene ether resin composition having improved heat stability, comprises a matrix of polyphenylene ether resin and dispersed therein, as stabilizer, a phosphonous acid or esterthereof of the formula wherein R1 represents an alkyl group, an aryl group which may be substituted by an alkyl group, an aralkyl group which may be substituted by an alkyl group, or a group of the formula (a) in which R. groups are identical or different alkyl groups, and R, and R, are identical or different and each represents a hydrogen atom, an alkyl group, an aryl group which may be substituted by an alkyl group, or an aralkyl group which may be substituted by an alkyl group, provided that when R, represents the group of formula (a), R, and R3 represent identical or different 2,4-dialkylphenyl groups.
    一种具有更好热稳定性的聚苯醚树脂组合物,包括聚苯醚树脂基体和分散在其中的 作为稳定剂的磷酸或其酯,其式如下 其中 R1 代表烷基、可被烷基取代的芳基、可被烷基取代的芳烷基或式(a)的基团 其中 R.基团是相同或不同的烷基,且 R,和 R,是相同或不同的,且各自代表氢原子、烷基、可被烷基取代的芳基或可被烷基取代的芳烷基,但当 R 代表式(a)的基团时,R,和 R3 代表相同或不同的 2,4-二烷基苯基。
  • Process for the preparation of a hydroxylamine
    申请人:AKZO N.V.
    公开号:EP0147879A1
    公开(公告)日:1985-07-10
    The present invention relates to a process for the preparation of organic hydroxylamines as a result of the corresponding nitroderivative being hydrogenated in the presence of an inert solvent, a platinum catalyst, a nitrogen-containing base (in an amount of less than 10% by weight calculated on the amount of nitro derivative) and a tri- or pentavalent organic phosphorus compound. It has been found that if only use is made of the nitrogen-containing base or the phosphorus compound the yields of isolated hydroxyl amine are significantly reduced in comparison with those obtained with the present process.
    本发明涉及一种制备有机羟胺的工艺,该工艺是相应的硝基衍生物在惰性溶剂、催化剂、含氮碱(按硝基衍生物量计算,其用量少于 10%(重量))和三价或五价有机化合物存在下氢化的结果。 研究发现,如果仅使用含氮碱或化合物,分离出的羟胺的产率与本工艺相比会明显降低。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫